Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Australia shares edge lower as virus cases resurge in Sydney

Published 21/12/2020, 11:41 am
© Reuters.

Dec 21 (Reuters) - Australian shares slipped marginally on Monday, with energy and financial stocks leading the declines, as a surge in COVID-19 cases in Sydney led states and territories to ban travellers from the city, stoking fears of a delayed economic recovery.

The S&P/ASX 200 index .AXJO edged 0.06% lower by 0009 GMT.

Projections of the Australian economy recovering from its first recession in three decades faster than previously anticipated were dismantled after Sydney, the country's most populous city, detected a new virus cluster which had grown to a count of around 70 as of Sunday. Australian Capital Territory (ACT) sent a stern "do not come to us" message to Sydney, warning its residents they would be quarantined for 14 days if they arrived.

The states of Victoria, Queensland, and the Northern Territory banned people arriving from Sydney as of Monday.

Among individual sectors and stocks, the energy sub-index .AXEJ fell as much as 1.8% to its lowest in nearly three weeks, as oil prices slipped.

Woodside Petroleum WPL.AX shed about 2.5% while Santos STO.AX declined as much as 2.2%.

The heavyweight financial index .AXFJ fell over 1% to hit a near three-week low. The "Big Four" banks slid between 0.3% and 1.1%.

Limiting losses on the benchmark, the healthcare sector .AXHJ gained 0.5%, with CSL CSL.AX rising 0.6% and Resmed Inc RMD.N climbing nearly 2% to its highest since Dec. 9.

Australian technology stocks .AXIJ added 1.2% with Afterpay APT.AX gaining over 5% and Tech One TNE.AX rising nearly 2%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Meanwhile, New Zealand's benchmark S&P/NZX 50 index .NZ50 dipped 0.02% to 12,680.06. Kathmandu Holdings KMD.NZ fell nearly 4% to a three-week low.

A2 Milk ATM.NZ lost as much as 5% to hit its lowest since Jan. 4, 2019, after Citi Research cut price target on the stock to A$9.50 from A$14.20, after the dairy company slashed its half-yearly and annual revenue outlook last week.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.